Passive income investors are spoilt for choice on the Australian share market, with the bourse filled to the brim with ASX dividend shares.
But which ones could be buys in February?
Let’s take a look at three that analysts are currently recommending to their clients. They are as follows:
HomeCo Daily Needs REIT (ASX: HDN)
The first ASX dividend share for income investors to look at is the HomeCo Daily Needs REIT.
It is a real estate investment trust (REIT) with a focus on convenience-based assets. This includes supermarkets, pharmacies, and medical clinics.
At the last count, the HomeCo Daily Needs REIT owned 47 properties with an average weighted lease expiry of 4.9 years and an impressive 99% occupancy.
UBS is a fan of the company and sees value in its shares at current levels. The broker currently has a buy rating and $1.53 price target on its shares.
As for income, it is expecting the company to reward shareholders with dividends of 8.6 cents per share in FY 2026 and then 8.7 cents per share in FY 2027. Based on its current share price of $1.26, this would mean dividend yields of 6.8% and 6.9%, respectively.
IPH Ltd (ASX: IPH)
Another ASX dividend share that has been given the thumbs up by analysts is IPH.
It is an international intellectual property services company with businesses operating across 26 jurisdictions. It counts Fortune Global 500 companies, multinationals, public sector research organisations, small businesses, and professional services firms as clients.
Morgans remains positive on IPH and is recommending it to clients. It believes the company is positioned to pay fully franked dividends of 37 cents per share in FY 2026 and FY 2027. Based on its current share price of $3.50, this would mean generous 10.5% dividend yields for both years.
Morgans has a buy rating and $6.05 price target on its shares.
Sonic Healthcare Ltd (ASX: SHL)
Finally, Bell Potter is tipping Sonic Healthcare as an ASX dividend share to buy.
It is a leading pathology and diagnostic imaging provider that has operations across Australia, Europe, and the United States.
Bell Potter believes the company’s performance is about to improve meaningfully and then be sustained. It notes that this is expected to be “driven by right sizing the business, the impact of acquisitions in FY24 and normalising organic operations post COVID.”
The broker expects this to support dividends per share of $1.09 in FY 2026 and then $1.11 in FY 2027. Based on its current share price of $22.02, this represents dividend yields of 4.8% and 4.9%, respectively.
Bell Potter currently has a buy rating and $33.30 price target on its shares.
The post 3 quality ASX dividend shares to buy for passive income in 2026 appeared first on The Motley Fool Australia.
Should you invest $1,000 in Homeco Daily Needs REIT right now?
Before you buy Homeco Daily Needs REIT shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Homeco Daily Needs REIT wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 Jan 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Forget term deposits and buy these ASX dividend shares
- Meet the ASX dividend stocks offering massive 6% to 10% yields
- These excellent ASX dividend shares offer 4% to 6.7% yields
- Aussie income stocks: A once-in-a-decade chance to get richer?
- 3 high-yield ASX dividend shares that smash term deposits
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended HomeCo Daily Needs REIT, IPH Ltd , and Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.